What is the treatment for endophthalmitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Endophthalmitis

Endophthalmitis requires immediate combined medical and surgical intervention with intravitreal antibiotics and vitrectomy in severe cases to prevent irreversible vision loss. 1

Diagnosis and Initial Assessment

  • Endophthalmitis is a sight-threatening infection involving inflammation of the vitreous and/or aqueous humor that requires rapid ophthalmologic intervention 2
  • Clinical presentation typically includes eye pain, decreased vision, and inflammatory findings such as hypopyon 1
  • Definitive diagnosis requires direct ophthalmoscopic examination and culture of vitreous humor or aqueous humor specimens 3
  • Diagnostic vitreous tap is essential before initiating treatment to identify the causative organism 3

Treatment Algorithm

Step 1: Immediate Intervention

  • Obtain emergency ophthalmology consultation for all suspected cases 1
  • Perform diagnostic vitreal tap to collect samples for culture and sensitivity testing 3

Step 2: Antimicrobial Therapy

For bacterial endophthalmitis:

  • Administer intravitreal antibiotics immediately after vitreous sampling 4
  • Consider pars plana vitrectomy for severe cases with significant vision loss 4

For fungal endophthalmitis (specifically Aspergillus):

  • Following diagnostic vitreal tap, administer intravenous amphotericin B (AMB) and intravitreal AMB when appropriate 3
  • Voriconazole administered intravitreally or systemically is an effective alternative regimen 3

For Candida endophthalmitis:

  • For fluconazole/voriconazole-susceptible isolates, use fluconazole (loading dose 800 mg, then 400-800 mg daily) or voriconazole (loading dose 400 mg IV twice daily for 2 doses, then 300 mg IV or oral twice daily) 3
  • For resistant isolates, use liposomal amphotericin B (3-5 mg/kg IV daily), with or without oral flucytosine (25 mg/kg 4 times daily) 3

Step 3: Surgical Management

  • Pars plana vitrectomy is sight-saving in severe cases by removing inflammatory debris and infectious organisms 3
  • For macular involvement, combine systemic antifungals with intravitreal injection of either amphotericin B deoxycholate (5-10 μg/0.1 mL sterile water) or voriconazole (100 μg/0.1 mL sterile water or normal saline) 3
  • More conservative measures, such as subconjunctival injection, are generally less successful 3

Special Considerations

Based on Etiology

  • Post-surgical endophthalmitis: Coagulase-negative staphylococci are most common after cataract surgery 2
  • Post-traumatic endophthalmitis: Bacillus cereus is a major cause; can occur even with imperceptible trauma 2, 5
  • Endogenous endophthalmitis: Staphylococcus aureus and streptococci are important causes associated with endocarditis; Candida species are common in hospitalized patients 2

Treatment Duration

  • Treatment should continue for at least 4-6 weeks, with final duration depending on resolution of lesions as determined by repeated ophthalmological examinations 3
  • For fungal endophthalmitis with prosthetic valve involvement, consider lifelong antifungal therapy with an oral triazole such as voriconazole or posaconazole 3

Prognosis and Monitoring

  • Visual outcomes depend on the virulence of the pathogen, extent of infection, and speed with which treatment is initiated 6
  • Direct macular involvement is a poor prognostic indicator for recovery of visual acuity 3
  • Regular ophthalmologic follow-up is essential to monitor response to treatment 3

Important Pitfalls to Avoid

  • Delayed treatment can result in permanent vision loss; endophthalmitis is a medical emergency 6
  • Subconjunctival antibiotic injections alone are generally ineffective and should not replace intravitreal administration 3
  • Failure to perform diagnostic vitreous sampling before initiating treatment may lead to inability to identify the causative organism 1
  • Endophthalmitis can masquerade as uveitis, leading to inappropriate treatment with steroids that may worsen infection 5

References

Research

High risk and low prevalence diseases: Endophthalmitis.

The American journal of emergency medicine, 2023

Research

Endophthalmitis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bacterial endophthalmitis.

Current infectious disease reports, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.